Trxade Group, Inc. Gains 34.37%
Trxade Group, Inc. (MEDS:NASDAQ) shot up at $25.53, a gain of 34.4%. On Fri, Mar 08, 2024, MEDS:NASDAQ hit a New 2-Week High of $25.53. The stock got featured on our News Catalysts scanner on Wed, Mar 06, 2024 at 10:37 AM in the 'INVESTOR UPDATE' category. From Fri, Feb 23, 2024, the stock recorded 60.00% Up Days and 45.45% Green Days
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Safe and Green Development Corporation (SGD:NASDAQ), 88.16%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 71.4%
- Semilux International Ltd. (SELX:NASDAQ), 69%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 66.14%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 61.61%
- Edoc Acquisition Corp. (ADOC:NASDAQ), 36.25%
- NWTN Inc. (NWTN:NASDAQ), 35.9%
- reAlpha Tech Corp. (AIRE:NASDAQ), 35.2%
- Trxade Group, Inc. (MEDS:NASDAQ), 34.37%